{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:42:15Z","timestamp":1776472935893,"version":"3.51.2"},"reference-count":36,"publisher":"Elsevier BV","issue":"9157","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1016\/s0140-6736(98)03053-0","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T15:42:52Z","timestamp":1027611772000},"page":"964-969","source":"Crossref","is-referenced-by-count":384,"title":["Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis"],"prefix":"10.1016","volume":"353","author":[{"given":"Ludwig","family":"Kappos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Moeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst Wilhelm","family":"Radue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schoetzau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kati","family":"Schweikert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles RG","family":"Guttmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard L","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(98)03053-0_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/brain\/121.1.3","article-title":"The role of magnetic resonance techniques in understanding and managing multiple sclerosis","volume":"121","author":"Miller","year":"1998","journal-title":"Brain"},{"key":"10.1016\/S0140-6736(98)03053-0_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00328179","article-title":"Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis","volume":"30","author":"Kappos","year":"1988","journal-title":"Neuroradiology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.45.7.1277","article-title":"Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial","volume":"45","author":"The IFNB Multiple Scerosis Study Group and the University of British Columbia MS\/MRI Analysis Group","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.410430114","article-title":"Magnetic resonance studies of intramuscular interferon \u03b2-1a for relapsing multiple sclerosis","volume":"43","author":"Simon","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/brain\/116.5.1077","article-title":"Gadolinium enhancement increases the sensitivity of MR in detecting disease activity in multiple sclerosis","volume":"116","author":"Miller","year":"1993","journal-title":"Brain"},{"key":"10.1016\/S0140-6736(98)03053-0_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01741450","article-title":"An attempt to quantify magnetic resonance imaging in multiple scerosis\u2014correlation with clinical parameters","volume":"10","author":"Kappos","year":"1987","journal-title":"Neurosurg Rev"},{"key":"10.1016\/S0140-6736(98)03053-0_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ana.410340507","article-title":"Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis","volume":"34","author":"Katz","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.410420515","article-title":"Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology","volume":"42","author":"Br\u00fcck","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1148\/radiology.161.3.3786722","article-title":"Multiple sclerosis: gadolinium enhancement in MR imaging","volume":"161","author":"Grossman","year":"1986","journal-title":"Radiology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2214\/ajr.159.5.1414773","article-title":"Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity","volume":"159","author":"Barkhof","year":"1992","journal-title":"AJR"},{"key":"10.1016\/S0140-6736(98)03053-0_bib12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ana.410330511","article-title":"Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentate dimeglumine-enhancing magnetic resonance imaging lesions","volume":"33","author":"Smith","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/brain\/121.3.495","article-title":"The prognostic value of brain MRI in clinically isolated syndromes of the CNS: a 10-year follow-up","volume":"121","author":"O'Riordan","year":"1998","journal-title":"Brain"},{"key":"10.1016\/S0140-6736(98)03053-0_bib14","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/WNL.44.11.2120","article-title":"Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden","volume":"44","author":"Khoury","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1212\/WNL.45.2.255","article-title":"Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study","volume":"45","author":"Filippi","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.62.3.285","article-title":"Gadolinium-enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis","volume":"67","author":"Koudriatseva","year":"1997","journal-title":"J Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(98)03053-0_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/135245859600100406","article-title":"Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis","volume":"1","author":"Lossef","year":"1996","journal-title":"Mult Scler"},{"key":"10.1016\/S0140-6736(98)03053-0_bib18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib19","first-page":"1549","article-title":"Serial contrast-enhanced MR in patients with multiple sclerosis and varying levels of disability","volume":"18","author":"Filippi","year":"1997","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/135245859700200604","article-title":"Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase III therapeutical trials","volume":"2","author":"Truyen","year":"1997","journal-title":"Mult Scler"},{"key":"10.1016\/S0140-6736(98)03053-0_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1212\/WNL.46.2.373","article-title":"Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis","volume":"46","author":"Thorpe","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.60.1.15","article-title":"MRI dynamics of brain and spinal cord in progressive multiple sclerosis","volume":"60","author":"Kidd","year":"1996","journal-title":"J Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(98)03053-0_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jnnp.61.3.251","article-title":"Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis","volume":"61","author":"Pozzilli","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(98)03053-0_bib24","first-page":"A174","article-title":"Roquinimex (Linomide) treatment in secondary progressive and relapsing remitting multiple sclerosis: results from 48 week randomized, double-blind, placebo-controlled pilot studies","volume":"48","author":"Hohol","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib25","first-page":"A410","article-title":"the 15\u00b1 Deoxyspergualine (DSG) in the treatment of active multiple sclerosis: final analysis of the European multicenter study","volume":"46","author":"Kappos","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.49.2.351","article-title":"Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial","volume":"48","author":"van Oosten","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/jnnp.54.8.683","article-title":"Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted Action Guidelines","volume":"54","author":"Miller","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0140-6736(98)03053-0_bib29","series-title":"Generalized linear models. In: monographs on statistics and applied probability no 37","first-page":"48","year":"1989"},{"key":"10.1016\/S0140-6736(98)03053-0_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0733-8619(18)30064-1","article-title":"The natural history of multiple sclerosis","volume":"13","author":"Weinshenker","year":"1995","journal-title":"Neurol Clin"},{"key":"10.1016\/S0140-6736(98)03053-0_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/135245859500100107","article-title":"Outcomes assessment in multiple sclerosis clinical trials: a critical analysis","volume":"1","author":"Whitaker","year":"1995","journal-title":"Mult Scler"},{"key":"10.1016\/S0140-6736(98)03053-0_bib32","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1212\/WNL.46.6.1613","article-title":"Meta-analysis of the placebo-treated groups in clinical trials of progressive MS","volume":"46","author":"Weinshenker","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.410430311","article-title":"Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis: a multi-centre longitudinal study","volume":"43","author":"Molyneux","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.47.6.1469","article-title":"Accumulation of hypointense lesions (\u201cblack holes\u201d) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis","volume":"47","author":"Truyen","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S0140-6736(98)03053-0_bib35","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1002\/ana.410360718","article-title":"Clinical scoring methods for multiple sclerosis","volume":"36","author":"Noseworthy","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/S0140-6736(98)03053-0_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s004150050053","article-title":"Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials","volume":"244","author":"Barkhof","year":"1997","journal-title":"J Neurol"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673698030530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673698030530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T16:35:06Z","timestamp":1578674106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673698030530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":36,"journal-issue":{"issue":"9157","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["S0140673698030530"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(98)03053-0","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}